10-Q Filing
Filing Information
| Form Type | 10-Q |
| Accession Number | 0000078003-21-000065 |
| Period End Date | 20210331 |
| Filing Date | 20210513 |
| Fiscal Year | 2021 |
| Fiscal Period | Q1 |
| XBRL Instance | pfe-20210404_htm.xml |
Filing Contents
This filing contains the following financial statements:
Balance Sheet
88 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$508.00M | USD | Point-in-time |
| Allowance for doubtful accounts |
AllowanceForDoubtfulAccountsReceivableCurrent
|
$512.00M | USD | Point-in-time |
| Property, plant and equipment, accumulated depreciation |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$15.11B | USD | Point-in-time |
| Property, plant and equipment, accumulated depreciation |
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
|
$14.81B | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$1.78B | USD | Point-in-time |
| Cash and cash equivalents |
CashAndCashEquivalentsAtCarryingValue
|
$1.77B | USD | Point-in-time |
| Short-term investments |
OtherShortTermInvestments
|
$11.90B | USD | Point-in-time |
| Short-term investments |
OtherShortTermInvestments
|
$10.44B | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$2.00B | USD | Point-in-time |
| Current portion of long-term debt |
LongTermDebtCurrent
|
$3.68B | USD | Point-in-time |
| Trade accounts receivable, less allowance for doubtful accounts: 2021$512; 2020$508 |
AccountsReceivableNetCurrent
|
$9.86B | USD | Point-in-time |
| Trade accounts receivable, less allowance for doubtful accounts: 2021$512; 2020$508 |
AccountsReceivableNetCurrent
|
$7.93B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$8.49B | USD | Point-in-time |
| Inventories |
InventoryNet
|
$8.05B | USD | Point-in-time |
| Current tax assets |
OtherTaxAssetsCurrent
|
$3.26B | USD | Point-in-time |
| Current tax assets |
OtherTaxAssetsCurrent
|
$3.42B | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$3.60B | USD | Point-in-time |
| Other current assets |
OtherAssetsCurrent
|
$4.09B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$39.53B | USD | Point-in-time |
| Total current assets |
AssetsCurrent
|
$35.07B | USD | Point-in-time |
| Equity-method investments |
EquityMethodInvestments
|
$16.53B | USD | Point-in-time |
| Equity-method investments |
EquityMethodInvestments
|
$16.86B | USD | Point-in-time |
| Long-term investments |
OtherLongTermInvestments
|
$3.41B | USD | Point-in-time |
| Long-term investments |
OtherLongTermInvestments
|
$3.70B | USD | Point-in-time |
| Property, plant and equipment, less accumulated depreciation: 2021$15,105; 2020$14,812 |
PropertyPlantAndEquipmentNet
|
$14.01B | USD | Point-in-time |
| Property, plant and equipment, less accumulated depreciation: 2021$15,105; 2020$14,812 |
PropertyPlantAndEquipmentNet
|
$13.90B | USD | Point-in-time |
| Identifiable intangible assets |
IntangibleAssetsNetExcludingGoodwill
|
$28.47B | USD | Point-in-time |
| Identifiable intangible assets |
IntangibleAssetsNetExcludingGoodwill
|
$27.97B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$49.58B | USD | Point-in-time |
| Goodwill |
Goodwill
|
$49.79B | USD | Point-in-time |
| Noncurrent deferred tax assets and other noncurrent tax assets |
DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent
|
$2.54B | USD | Point-in-time |
| Noncurrent deferred tax assets and other noncurrent tax assets |
DeferredTaxAssetsNetAndOtherTaxAssetsNoncurrent
|
$2.38B | USD | Point-in-time |
| Other noncurrent assets |
OtherAssetsNoncurrent
|
$4.57B | USD | Point-in-time |
| Other noncurrent assets |
OtherAssetsNoncurrent
|
$4.74B | USD | Point-in-time |
| Total assets |
Assets
|
$154.23B | USD | Point-in-time |
| Total assets |
Assets
|
$158.82B | USD | Point-in-time |
| Short-term borrowings, including current portion of long-term debt: 2021$3,676; 2020$2,002 |
DebtCurrent
|
$2.70B | USD | Point-in-time |
| Short-term borrowings, including current portion of long-term debt: 2021$3,676; 2020$2,002 |
DebtCurrent
|
$4.35B | USD | Point-in-time |
| Trade accounts payable |
AccountsPayableCurrent
|
$4.31B | USD | Point-in-time |
| Trade accounts payable |
AccountsPayableCurrent
|
$4.06B | USD | Point-in-time |
| Dividends payable |
DividendsPayableCurrent
|
- | USD | Point-in-time |
| Dividends payable |
DividendsPayableCurrent
|
$2.16B | USD | Point-in-time |
| Income taxes payable |
TaxesPayableCurrent
|
$1.40B | USD | Point-in-time |
| Income taxes payable |
TaxesPayableCurrent
|
$1.05B | USD | Point-in-time |
| Accrued compensation and related items |
EmployeeRelatedLiabilitiesCurrent
|
$3.06B | USD | Point-in-time |
| Accrued compensation and related items |
EmployeeRelatedLiabilitiesCurrent
|
$1.99B | USD | Point-in-time |
| Deferred revenues |
ContractWithCustomerLiabilityCurrent
|
$1.11B | USD | Point-in-time |
| Deferred revenues |
ContractWithCustomerLiabilityCurrent
|
$2.05B | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$12.80B | USD | Point-in-time |
| Other current liabilities |
OtherLiabilitiesCurrent
|
$11.53B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$25.92B | USD | Point-in-time |
| Total current liabilities |
LiabilitiesCurrent
|
$26.65B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$35.35B | USD | Point-in-time |
| Long-term debt |
LongTermDebtNoncurrent
|
$37.13B | USD | Point-in-time |
| Pension benefit obligations |
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
$4.53B | USD | Point-in-time |
| Pension benefit obligations |
DefinedBenefitPensionPlanLiabilitiesNoncurrent
|
$4.77B | USD | Point-in-time |
| Postretirement benefit obligations |
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
|
$635.00M | USD | Point-in-time |
| Postretirement benefit obligations |
OtherPostretirementDefinedBenefitPlanLiabilitiesNoncurrent
|
$645.00M | USD | Point-in-time |
| Noncurrent deferred tax liabilities |
DeferredIncomeTaxLiabilitiesNet
|
$4.36B | USD | Point-in-time |
| Noncurrent deferred tax liabilities |
DeferredIncomeTaxLiabilitiesNet
|
$4.06B | USD | Point-in-time |
| Other taxes payable |
LiabilityForUncertainTaxPositionsNoncurrent
|
$11.76B | USD | Point-in-time |
| Other taxes payable |
LiabilityForUncertainTaxPositionsNoncurrent
|
$11.56B | USD | Point-in-time |
| Other noncurrent liabilities |
OtherLiabilitiesNoncurrent
|
$6.68B | USD | Point-in-time |
| Other noncurrent liabilities |
OtherLiabilitiesNoncurrent
|
$6.67B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$89.95B | USD | Point-in-time |
| Total liabilities |
Liabilities
|
$90.76B | USD | Point-in-time |
| Commitments and Contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Commitments and Contingencies |
CommitmentsAndContingencies
|
- | USD | Point-in-time |
| Common stock |
CommonStockValue
|
$470.00M | USD | Point-in-time |
| Common stock |
CommonStockValue
|
$472.00M | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$89.00B | USD | Point-in-time |
| Additional paid-in capital |
AdditionalPaidInCapital
|
$88.67B | USD | Point-in-time |
| Treasury stock |
TreasuryStockValue
|
$111.35B | USD | Point-in-time |
| Treasury stock |
TreasuryStockValue
|
$110.99B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$90.39B | USD | Point-in-time |
| Retained earnings |
RetainedEarningsAccumulatedDeficit
|
$95.16B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-5.31B | USD | Point-in-time |
| Accumulated other comprehensive loss |
AccumulatedOtherComprehensiveIncomeLossNetOfTax
|
$-4.66B | USD | Point-in-time |
| Total Pfizer Inc. shareholders equity |
StockholdersEquity
|
$68.62B | USD | Point-in-time |
| Total Pfizer Inc. shareholders equity |
StockholdersEquity
|
$63.24B | USD | Point-in-time |
| Equity attributable to noncontrolling interests |
MinorityInterest
|
$235.00M | USD | Point-in-time |
| Equity attributable to noncontrolling interests |
MinorityInterest
|
$245.00M | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$68.86B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$63.45B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$63.47B | USD | Point-in-time |
| Total equity |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$65.34B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$158.82B | USD | Point-in-time |
| Total liabilities and equity |
LiabilitiesAndStockholdersEquity
|
$154.23B | USD | Point-in-time |
Income Statement
46 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$10.08B | USD | 1 Quarter |
| Revenues |
RevenueFromContractWithCustomerExcludingAssessedTax
|
$14.58B | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$1.94B | USD | 1 Quarter |
| Cost of sales |
CostOfGoodsAndServicesSold
|
$4.21B | USD | 1 Quarter |
| Selling, informational and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$2.54B | USD | 1 Quarter |
| Selling, informational and administrative expenses |
SellingGeneralAndAdministrativeExpense
|
$2.78B | USD | 1 Quarter |
| Research and development expenses |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$1.67B | USD | 1 Quarter |
| Research and development expenses |
ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost
|
$2.01B | USD | 1 Quarter |
| Amortization of intangible assets |
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
|
$872.00M | USD | 1 Quarter |
| Amortization of intangible assets |
AmortizationOfIntangibleAssetsNotAssociatedWithSingleFunction
|
$849.00M | USD | 1 Quarter |
| Restructuring charges and certain acquisition-related costs |
RestructuringChargesAndAcquisitionRelatedCosts
|
$23.00M | USD | 1 Quarter |
| Restructuring charges and certain acquisition-related costs |
RestructuringChargesAndAcquisitionRelatedCosts
|
$54.00M | USD | 1 Quarter |
| (Gain) on completion of Consumer Healthcare JV transaction |
DeconsolidationGainOrLossAmount
|
$6.00M | USD | 1 Quarter |
| (Gain) on completion of Consumer Healthcare JV transaction |
DeconsolidationGainOrLossAmount
|
- | USD | 1 Quarter |
| Other (income)/deductionsnet |
OtherNonoperatingIncomeExpense
|
$1.00B | USD | 1 Quarter |
| Other (income)/deductionsnet |
OtherNonoperatingIncomeExpense
|
$-190.00M | USD | 1 Quarter |
| Income from continuing operations before provision for taxes on income |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$5.68B | USD | 1 Quarter |
| Income from continuing operations before provision for taxes on income |
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
$2.84B | USD | 1 Quarter |
| Provision for taxes on income |
IncomeTaxExpenseBenefit
|
$805.00M | USD | 1 Quarter |
| Provision for taxes on income |
IncomeTaxExpenseBenefit
|
$359.00M | USD | 1 Quarter |
| Income from continuing operations |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$4.88B | USD | 1 Quarter |
| Income from continuing operations |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$2.48B | USD | 1 Quarter |
| Income from discontinued operationsnet of tax |
IncomeLossFromDiscontinuedOperationsNetOfTax
|
$881.00M | USD | 1 Quarter |
| Income from discontinued operationsnet of tax |
IncomeLossFromDiscontinuedOperationsNetOfTax
|
$9.00M | USD | 1 Quarter |
| Net income before allocation to noncontrolling interests |
ProfitLoss
|
$4.89B | USD | 1 Quarter |
| Net income before allocation to noncontrolling interests |
ProfitLoss
|
$3.36B | USD | 1 Quarter |
| Less: Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$9.00M | USD | 1 Quarter |
| Less: Net income attributable to noncontrolling interests |
NetIncomeLossAttributableToNoncontrollingInterest
|
$9.00M | USD | 1 Quarter |
| Net income attributable to Pfizer Inc. common shareholders |
NetIncomeLoss
|
$4.88B | USD | 1 Quarter |
| Net income attributable to Pfizer Inc. common shareholders |
NetIncomeLoss
|
$3.35B | USD | 1 Quarter |
| Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.45 | USD | 1 Quarter |
| Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) |
IncomeLossFromContinuingOperationsPerBasicShare
|
$0.87 | USD | 1 Quarter |
| Income from discontinued operationsnet of tax (in dollars per share) |
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
- | USD | 1 Quarter |
| Income from discontinued operationsnet of tax (in dollars per share) |
IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare
|
$0.16 | USD | 1 Quarter |
| Net income attributable to Pfizer Inc. common shareholders (in dollars per share) |
EarningsPerShareBasic
|
$0.60 | USD | 1 Quarter |
| Net income attributable to Pfizer Inc. common shareholders (in dollars per share) |
EarningsPerShareBasic
|
$0.87 | USD | 1 Quarter |
| Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.44 | USD | 1 Quarter |
| Income from continuing operations attributable to Pfizer Inc. common shareholders (in dollars per share) |
IncomeLossFromContinuingOperationsPerDilutedShare
|
$0.86 | USD | 1 Quarter |
| Income from discontinued operationsnet of tax (in dollars per share) |
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
- | USD | 1 Quarter |
| Income from discontinued operationsnet of tax (in dollars per share) |
IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare
|
$0.16 | USD | 1 Quarter |
| Net income attributable to Pfizer Inc. common shareholders (in dollars per share) |
EarningsPerShareDiluted
|
$0.86 | USD | 1 Quarter |
| Net income attributable to Pfizer Inc. common shareholders (in dollars per share) |
EarningsPerShareDiluted
|
$0.60 | USD | 1 Quarter |
| Weighted-average sharesbasic |
WeightedAverageNumberOfSharesOutstandingBasic
|
5.58B | shares | 1 Quarter |
| Weighted-average sharesbasic |
WeightedAverageNumberOfSharesOutstandingBasic
|
5.54B | shares | 1 Quarter |
| Weighted-average sharesdiluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
5.61B | shares | 1 Quarter |
| Weighted-average sharesdiluted |
WeightedAverageNumberOfDilutedSharesOutstanding
|
5.66B | shares | 1 Quarter |
Cash Flow Statement
82 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income before allocation to noncontrolling interests |
ProfitLoss
|
$4.89B | USD | 1 Quarter |
| Net income before allocation to noncontrolling interests |
ProfitLoss
|
$3.36B | USD | 1 Quarter |
| Income from discontinued operationsnet of tax |
IncomeLossFromDiscontinuedOperationsNetOfTax
|
$9.00M | USD | 1 Quarter |
| Income from discontinued operationsnet of tax |
IncomeLossFromDiscontinuedOperationsNetOfTax
|
$881.00M | USD | 1 Quarter |
| Net income from continuing operations before allocation to noncontrolling interests |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$2.48B | USD | 1 Quarter |
| Net income from continuing operations before allocation to noncontrolling interests |
IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest
|
$4.88B | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization
|
$1.17B | USD | 1 Quarter |
| Depreciation and amortization |
DepreciationDepletionAndAmortizationIncludingDiscontinuedOperationDepreciationandAmortization
|
$1.23B | USD | 1 Quarter |
| Asset write-offs and impairments |
AssetWriteOffsAndAssetImpairmentCharges
|
$46.00M | USD | 1 Quarter |
| Asset write-offs and impairments |
AssetWriteOffsAndAssetImpairmentCharges
|
$44.00M | USD | 1 Quarter |
| Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed |
DeconsolidationGainLossAmountNetOfCashConveyed
|
- | USD | 1 Quarter |
| Gain on completion of Consumer Healthcare JV transaction, net of cash conveyed |
DeconsolidationGainLossAmountNetOfCashConveyed
|
$6.00M | USD | 1 Quarter |
| Deferred taxes from continuing operations |
DeferredIncomeTaxExpenseBenefit
|
$82.00M | USD | 1 Quarter |
| Deferred taxes from continuing operations |
DeferredIncomeTaxExpenseBenefit
|
$199.00M | USD | 1 Quarter |
| Share-based compensation expense |
ShareBasedCompensation
|
$172.00M | USD | 1 Quarter |
| Share-based compensation expense |
ShareBasedCompensation
|
$57.00M | USD | 1 Quarter |
| Benefit plan contributions in excess of expense/income |
PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense
|
$276.00M | USD | 1 Quarter |
| Benefit plan contributions in excess of expense/income |
PensionAndOtherPostretirementBenefitContributionsNetOfPensionAndOtherPostretirementBenefitExpense
|
$373.00M | USD | 1 Quarter |
| Other adjustments, net |
OtherNoncashIncomeExpense
|
$291.00M | USD | 1 Quarter |
| Other adjustments, net |
OtherNoncashIncomeExpense
|
$-120.00M | USD | 1 Quarter |
| Other changes in assets and liabilities, net of acquisitions and divestitures |
IncreaseDecreaseInOperatingCapital
|
$1.33B | USD | 1 Quarter |
| Other changes in assets and liabilities, net of acquisitions and divestitures |
IncreaseDecreaseInOperatingCapital
|
$1.51B | USD | 1 Quarter |
| Net cash provided by operating activities from continuing operations |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$2.15B | USD | 1 Quarter |
| Net cash provided by operating activities from continuing operations |
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
|
$4.53B | USD | 1 Quarter |
| Net cash provided by operating activities from discontinued operations |
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
$978.00M | USD | 1 Quarter |
| Net cash provided by operating activities from discontinued operations |
CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations
|
$9.00M | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$3.13B | USD | 1 Quarter |
| Net cash provided by operating activities |
NetCashProvidedByUsedInOperatingActivities
|
$4.54B | USD | 1 Quarter |
| Purchases of property, plant and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$449.00M | USD | 1 Quarter |
| Purchases of property, plant and equipment |
PaymentsToAcquirePropertyPlantAndEquipment
|
$554.00M | USD | 1 Quarter |
| Purchases of short-term investments |
PaymentsToAcquireShortTermInvestments
|
$6.05B | USD | 1 Quarter |
| Purchases of short-term investments |
PaymentsToAcquireShortTermInvestments
|
$2.55B | USD | 1 Quarter |
| Proceeds from redemptions/sales of short-term investments |
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
$5.46B | USD | 1 Quarter |
| Proceeds from redemptions/sales of short-term investments |
ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments
|
$3.26B | USD | 1 Quarter |
| Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less |
PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess
|
$996.00M | USD | 1 Quarter |
| Net (purchases of)/proceeds from redemptions/sales of short-term investments with original maturities of three months or less |
PaymentsForProceedsFromShortTermInvestmentsWithOriginalMaturitiesOfThreeMonthsOrLess
|
$416.00M | USD | 1 Quarter |
| Purchases of long-term investments |
PaymentsToAcquireMarketableSecurities
|
$22.00M | USD | 1 Quarter |
| Purchases of long-term investments |
PaymentsToAcquireMarketableSecurities
|
$27.00M | USD | 1 Quarter |
| Proceeds from redemptions/sales of long-term investments |
ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments
|
$152.00M | USD | 1 Quarter |
| Proceeds from redemptions/sales of long-term investments |
ProceedsFromSaleMaturityAndCollectionOfLongtermInvestments
|
$256.00M | USD | 1 Quarter |
| Other investing activities, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$24.00M | USD | 1 Quarter |
| Other investing activities, net |
PaymentsForProceedsFromOtherInvestingActivities
|
$-163.00M | USD | 1 Quarter |
| Net cash provided by/(used in) investing activities from continuing operations |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-53.00M | USD | 1 Quarter |
| Net cash provided by/(used in) investing activities from continuing operations |
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
|
$-1.75B | USD | 1 Quarter |
| Net cash provided by/(used in) investing activities from discontinued operations |
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
- | USD | 1 Quarter |
| Net cash provided by/(used in) investing activities from discontinued operations |
CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations
|
$-19.00M | USD | 1 Quarter |
| Net cash provided by/(used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-71.00M | USD | 1 Quarter |
| Net cash provided by/(used in) investing activities |
NetCashProvidedByUsedInInvestingActivities
|
$-1.75B | USD | 1 Quarter |
| Proceeds from short-term borrowings |
ProceedsFromShortTermDebt
|
$5.30B | USD | 1 Quarter |
| Proceeds from short-term borrowings |
ProceedsFromShortTermDebt
|
- | USD | 1 Quarter |
| Principal payments on short-term borrowings |
RepaymentsOfShortTermDebt
|
- | USD | 1 Quarter |
| Principal payments on short-term borrowings |
RepaymentsOfShortTermDebt
|
$7.55B | USD | 1 Quarter |
| Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less |
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
|
$3.21B | USD | 1 Quarter |
| Net (payments on)/proceeds from short-term borrowings with original maturities of three months or less |
ProceedsFromRepaymentsOfShortTermDebtMaturingInThreeMonthsOrLess
|
$-25.00M | USD | 1 Quarter |
| Proceeds from issuance of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
- | USD | 1 Quarter |
| Proceeds from issuance of long-term debt |
ProceedsFromIssuanceOfLongTermDebt
|
$1.24B | USD | 1 Quarter |
| Principal payments on long-term debt |
RepaymentsOfLongTermDebt
|
- | USD | 1 Quarter |
| Principal payments on long-term debt |
RepaymentsOfLongTermDebt
|
$2.18B | USD | 1 Quarter |
| Cash dividends paid |
PaymentsOfOrdinaryDividends
|
$2.10B | USD | 1 Quarter |
| Cash dividends paid |
PaymentsOfOrdinaryDividends
|
$2.17B | USD | 1 Quarter |
| Other financing activities, net |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-610.00M | USD | 1 Quarter |
| Other financing activities, net |
ProceedsFromPaymentsForOtherFinancingActivities
|
$-113.00M | USD | 1 Quarter |
| Net cash provided by/(used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-2.20B | USD | 1 Quarter |
| Net cash provided by/(used in) financing activities |
NetCashProvidedByUsedInFinancingActivities
|
$-2.81B | USD | 1 Quarter |
| Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$-15.00M | USD | 1 Quarter |
| Effect of exchange-rate changes on cash and cash equivalents and restricted cash and cash equivalents |
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
- | USD | 1 Quarter |
| Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$-15.00M | USD | 1 Quarter |
| Net increase/(decrease) in cash and cash equivalents and restricted cash and cash equivalents |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
$846.00M | USD | 1 Quarter |
| Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.82B | USD | Point-in-time |
| Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.35B | USD | Point-in-time |
| Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.81B | USD | Point-in-time |
| Cash and cash equivalents and restricted cash and cash equivalents, at beginning of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.20B | USD | Point-in-time |
| Cash and cash equivalents and restricted cash and cash equivalents, at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.81B | USD | Point-in-time |
| Cash and cash equivalents and restricted cash and cash equivalents, at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$2.20B | USD | Point-in-time |
| Cash and cash equivalents and restricted cash and cash equivalents, at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.35B | USD | Point-in-time |
| Cash and cash equivalents and restricted cash and cash equivalents, at end of period |
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
$1.82B | USD | Point-in-time |
| Income taxes |
IncomeTaxesPaidNet
|
$394.00M | USD | 1 Quarter |
| Income taxes |
IncomeTaxesPaidNet
|
$239.00M | USD | 1 Quarter |
| Interest paid |
InterestPaidNet
|
$445.00M | USD | 1 Quarter |
| Interest paid |
InterestPaidNet
|
$472.00M | USD | 1 Quarter |
| Interest rate hedges |
InterestPaidReceivedInterestRateHedges
|
$10.00M | USD | 1 Quarter |
| Interest rate hedges |
InterestPaidReceivedInterestRateHedges
|
$-11.00M | USD | 1 Quarter |
Stockholders Equity
28 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Cash dividends declared per share (in dollars per share) |
CommonStockDividendsPerShareDeclared
|
- | USD | 1 Quarter |
| Cash dividends declared per share (in dollars per share) |
CommonStockDividendsPerShareDeclared
|
- | USD | 1 Quarter |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$63.45B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$63.47B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$68.86B | USD | Point-in-time |
| Beginning balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$65.34B | USD | Point-in-time |
| Net income |
ProfitLoss
|
$4.89B | USD | 1 Quarter |
| Net income |
ProfitLoss
|
$3.36B | USD | 1 Quarter |
| Other comprehensive income/(loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$-1.44B | USD | 1 Quarter |
| Other comprehensive income/(loss), net of tax |
OtherComprehensiveIncomeLossNetOfTax
|
$647.00M | USD | 1 Quarter |
| Common stock |
DividendsCommonStockCash
|
$71.00M | USD | 1 Quarter |
| Common stock |
DividendsCommonStockCash
|
$84.00M | USD | 1 Quarter |
| Preferred stock |
DividendsPreferredStockCash
|
- | USD | 1 Quarter |
| Preferred stock |
DividendsPreferredStockCash
|
- | USD | 1 Quarter |
| Noncontrolling interests |
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
- | USD | 1 Quarter |
| Noncontrolling interests |
MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders
|
- | USD | 1 Quarter |
| Share-based payment transactions |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$44.00M | USD | 1 Quarter |
| Share-based payment transactions |
StockIssuedDuringPeriodValueShareBasedCompensation
|
$-30.00M | USD | 1 Quarter |
| Purchases of common stock |
TreasuryStockValueAcquiredCostMethod
|
- | USD | 1 Quarter |
| Purchases of common stock |
TreasuryStockValueAcquiredCostMethod
|
- | USD | 1 Quarter |
| Preferred stock conversions and redemptions |
StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock
|
- | USD | 1 Quarter |
| Preferred stock conversions and redemptions |
StockIssuedAndRedeemedDuringPeriodValueConversionAndRedemptionofStock
|
$1.00M | USD | 1 Quarter |
| Other |
StockholdersEquityOther
|
$27.00M | USD | 1 Quarter |
| Other |
StockholdersEquityOther
|
- | USD | 1 Quarter |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$68.86B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$63.45B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$63.47B | USD | Point-in-time |
| Ending balance |
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
|
$65.34B | USD | Point-in-time |
Comprehensive Income
34 line items
| Line Item | Tag | Value | Unit | Period |
|---|---|---|---|---|
| Net income before allocation to noncontrolling interests |
ProfitLoss
|
$4.89B | USD | 1 Quarter |
| Net income before allocation to noncontrolling interests |
ProfitLoss
|
$3.36B | USD | 1 Quarter |
| Foreign currency translation adjustments, net |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
$465.00M | USD | 1 Quarter |
| Foreign currency translation adjustments, net |
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
|
$-1.26B | USD | 1 Quarter |
| Unrealized holding gains/(losses) on derivative financial instruments, net |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
|
$214.00M | USD | 1 Quarter |
| Unrealized holding gains/(losses) on derivative financial instruments, net |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAndTax
|
$-501.00M | USD | 1 Quarter |
| Reclassification adjustments for (gains)/losses included in net income |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
|
$-259.00M | USD | 1 Quarter |
| Reclassification adjustments for (gains)/losses included in net income |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationBeforeTax
|
$-19.00M | USD | 1 Quarter |
| Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
|
$-482.00M | USD | 1 Quarter |
| Other comprehensive income (loss), derivatives qualifying as hedges, before tax, total |
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationBeforeTax
|
$473.00M | USD | 1 Quarter |
| Unrealized holding gains/(losses) on available-for-sale securities, net |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$79.00M | USD | 1 Quarter |
| Unrealized holding gains/(losses) on available-for-sale securities, net |
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax
|
$-51.00M | USD | 1 Quarter |
| Reclassification adjustments for (gains)/losses included in net income |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$-15.00M | USD | 1 Quarter |
| Reclassification adjustments for (gains)/losses included in net income |
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax
|
$242.00M | USD | 1 Quarter |
| Other comprehensive income (loss), available-for-sale securities, before tax, total |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
$-36.00M | USD | 1 Quarter |
| Other comprehensive income (loss), available-for-sale securities, before tax, total |
OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeTax
|
$-163.00M | USD | 1 Quarter |
| Reclassification adjustments related to amortization of prior service costs and other, net |
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
|
$-40.00M | USD | 1 Quarter |
| Reclassification adjustments related to amortization of prior service costs and other, net |
OtherComprehensiveIncomeLossAmortizationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetPriorServiceCostCreditBeforeTax
|
$-45.00M | USD | 1 Quarter |
| Other |
OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax
|
$1.00M | USD | 1 Quarter |
| Other |
OtherComprehensiveIncomeLossPensionandOtherPostretirementBenefitPlansOtherNetPriorServiceCostCreditArisingDuringPeriodbeforeTax
|
$3.00M | USD | 1 Quarter |
| Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax |
DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
|
$43.00M | USD | 1 Quarter |
| Defined benefit plan, amounts recognized in other comprehensive income (loss), net prior service cost, before tax |
DefinedBenefitPlanAmountsRecognizedInOtherComprehensiveIncomeNetPriorServiceCostCreditBeforeTax
|
$45.00M | USD | 1 Quarter |
| Other comprehensive income/(loss), before tax |
OtherComprehensiveIncomeLossBeforeTax
|
$732.00M | USD | 1 Quarter |
| Other comprehensive income/(loss), before tax |
OtherComprehensiveIncomeLossBeforeTax
|
$-1.82B | USD | 1 Quarter |
| Tax provision/(benefit) on other comprehensive income/(loss) |
OtherComprehensiveIncomeLossTax
|
$84.00M | USD | 1 Quarter |
| Tax provision/(benefit) on other comprehensive income/(loss) |
OtherComprehensiveIncomeLossTax
|
$-380.00M | USD | 1 Quarter |
| Other comprehensive income/(loss) before allocation to noncontrolling interests |
OtherComprehensiveIncomeLossNetOfTax
|
$-1.44B | USD | 1 Quarter |
| Other comprehensive income/(loss) before allocation to noncontrolling interests |
OtherComprehensiveIncomeLossNetOfTax
|
$647.00M | USD | 1 Quarter |
| Comprehensive income/(loss) before allocation to noncontrolling interests |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$5.53B | USD | 1 Quarter |
| Comprehensive income/(loss) before allocation to noncontrolling interests |
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
|
$1.92B | USD | 1 Quarter |
| Less: Comprehensive income/(loss) attributable to noncontrolling interests |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$9.00M | USD | 1 Quarter |
| Less: Comprehensive income/(loss) attributable to noncontrolling interests |
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
|
$10.00M | USD | 1 Quarter |
| Comprehensive income/(loss) attributable to Pfizer Inc. |
ComprehensiveIncomeNetOfTax
|
$1.91B | USD | 1 Quarter |
| Comprehensive income/(loss) attributable to Pfizer Inc. |
ComprehensiveIncomeNetOfTax
|
$5.52B | USD | 1 Quarter |
Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.